Patient information high on MHRA agenda
August 22, 2007Medical Communications patients
The MHRA has launched a wide-ranging consultation on its future direction, and improving information for patients is a key topic …
Improve services or lose out to private sector, government warns GPs
August 21, 2007The Department of Health has sent out a strongly-worded warning to England's GPs, telling them they must open in evenings …
Roche unveils Pegasys compliance service
August 21, 2007Medical Communications compliance, patients
Roche has set up a new multimedia service to support patients prescribed its hepatitis C treatment, Pegasys.Roche has been a …
Media buyers Bartlett Davis join ABPI
August 21, 2007ABPI
Bartlett Davis Communications has joined the ABPI, a move that acknowledges the increasing demands its code of practice places on …
Amgen to cut jobs on the back of sales slide
August 20, 2007Sales and Marketing Amgen
Amgen, one of the world's most successful biotech companies is to cut its staff numbers by up to 14% in …
Helping brands see round corners
August 20, 2007Sales and Marketing market research, marketing, sales, survey
Helping brand teams cope with climate changeThis year marked the 50th Anniversary of the Market Research Society. At the MRS …
10 steps to a more effective e-detail
August 20, 2007Medical Communications, Sales and Marketing creativity, e-detailing, marketing
With so many pharma companies still to take up e-detailing, experience of moving along the learning curve is proving to …
News roundup from Datamonitor
August 17, 2007Research and Development, Sales and Marketing
Cel-Sci secures manufacturing facility for Multikine cancer drugCel-Sci has entered into an agreement with a biomedical real estate group under …
Two companies to supply UK with pandemic flu vaccines
August 16, 2007Sales and Marketing
Baxter and GSK have been awarded contracts by the UK government to supply vaccines in the event of a flu …
US direct-to-consumer advertising attacked
August 16, 2007Sales and Marketing
Direct-to-consumer advertising by the US pharmaceutical industry has come under attack again, with the latest research showing that promotion of …
Conflict over plans to improve out-of-hours services
August 15, 2007Doctors have attacked government plans to allow more non-medically qualified staff to run out-of-hours services.The row follows a recent report …
Is London’s revamp a taste of things to come for the NHS?
August 15, 2007A review of the NHS in London has recommended setting up a network of 150 polyclinics to take on much …
News from Datamonitor
August 13, 2007Research and Development, Sales and Marketing
Alnylam lands $38.6 million federal government contractAlnylam Pharmaceuticals has been awarded a $38.6 million contract over 33 months from the …
The NHS and pharma: Let’s work together
August 13, 2007Research and Development, Sales and Marketing NHS, healthcare, industry relations, joint working, pharma
In the last 10 years, pharma’s relationship with the NHS has undergone a transformation. For one thing, it’s difficult now …
NICE claims victory in Alzheimer’s court case
August 10, 2007Sales and Marketing Alzheimer's
NICE will have to issue new guidance on Alzheimer's drugs, but claims the ruling in the judicial review vindicates its …
NICE to re-think blindness drugs decision
August 9, 2007Sales and Marketing AMD, Lucentis, Macugen, NICE
NICE will delay issuing final guidance on two blindness drugs after an unprecedented patient outcry over its decision to block …
FDA approves Pfizer’s first-in-class HIV drug
August 8, 2007Sales and Marketing HIV
Pfizer has won US approval for Selzentry, making it the first new class of oral HIV medicines to reach the …
Indian court dismisses Novartis patent claim
August 8, 2007Sales and Marketing India, Novartis
Novartis has failed in its challenge to India's intellectual property laws as part of its attempt to secure a patent …
Bayer buoyed by Schering integration
August 8, 2007Sales and Marketing
Bayer more than doubled its second quarter pharma sales, which rose to €2.6 billion on the back of the group's …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
